Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantin Lapa

Showing results (61-70 of 317) with videos related to

Pageof 32
Sort By:
Clinical Nuclear Medicine|December 30, 2014
Paralytic subileus as an adverse effect of amino acid-based nephroprotection in a patient undergoing peptide receptor radionuclide therapyRudolf A Werner, Joachim Brumberg, Alexander Dierks, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2023
Intense PSMA expression of the uvula detected by [<sup>68</sup> Ga]Ga-PSMA-PET/CTLisa Glantschnig, Alexander Dierks, Georgine Wienand, et al.
EJNMMI Research|September 29, 2012
68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factorsXiang Li, Samuel Samnick, Constantin Lapa, et al.
EJNMMI Physics|July 25, 2019
Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimatorsJoachim Brumberg, Ganna Blazhenets, Nils Schröter, et al.
Annals of Medicine|October 30, 2015
Activation of brown adipose tissue in hypothyroidismConstantin Lapa, Yoshifumi Maya, Martin Wagner, et al.
Lancet (London, England)|February 17, 2024
<sup>18</sup>fluorodeoxyglucose PET/CT as possible early diagnostic tool preceding MRI changes in Borna disease virus 1 encephalitisAntonios Bayas, Martina Menacher, Constantin Lapa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2015
DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine TherapyUta Eberlein, Harry Scherthan, Christina Bluemel, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2025
Deciphering the structural impact of norepinephrine analog radiopharmaceuticals on organic cation transporter affinitySaskia Mühlig, Xinyu Chen, Anna Tutov, et al.
Nuclear Medicine Communications|August 30, 2014
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?Rudolf A Werner, Christina Bluemel, Constantin Lapa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2020
Prognostic implications of dual tracer PET/CT: PSMA ligand and [<sup>18</sup>F]FDG PET/CT in patients undergoing [<sup>177</sup>Lu]PSMA radioligand therapyKerstin Michalski, Juri Ruf, Christian Goetz, et al.
Pageof 32

Showing results (61-70 of 317) with videos related to

Sort By:
Pageof 32
Clinical Nuclear Medicine|December 30, 2014
Paralytic subileus as an adverse effect of amino acid-based nephroprotection in a patient undergoing peptide receptor radionuclide therapyRudolf A Werner, Joachim Brumberg, Alexander Dierks, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2023
Intense PSMA expression of the uvula detected by [<sup>68</sup> Ga]Ga-PSMA-PET/CTLisa Glantschnig, Alexander Dierks, Georgine Wienand, et al.
EJNMMI Research|September 29, 2012
68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factorsXiang Li, Samuel Samnick, Constantin Lapa, et al.
EJNMMI Physics|July 25, 2019
Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimatorsJoachim Brumberg, Ganna Blazhenets, Nils Schröter, et al.
Annals of Medicine|October 30, 2015
Activation of brown adipose tissue in hypothyroidismConstantin Lapa, Yoshifumi Maya, Martin Wagner, et al.
Lancet (London, England)|February 17, 2024
<sup>18</sup>fluorodeoxyglucose PET/CT as possible early diagnostic tool preceding MRI changes in Borna disease virus 1 encephalitisAntonios Bayas, Martina Menacher, Constantin Lapa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2015
DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine TherapyUta Eberlein, Harry Scherthan, Christina Bluemel, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2025
Deciphering the structural impact of norepinephrine analog radiopharmaceuticals on organic cation transporter affinitySaskia Mühlig, Xinyu Chen, Anna Tutov, et al.
Nuclear Medicine Communications|August 30, 2014
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?Rudolf A Werner, Christina Bluemel, Constantin Lapa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2020
Prognostic implications of dual tracer PET/CT: PSMA ligand and [<sup>18</sup>F]FDG PET/CT in patients undergoing [<sup>177</sup>Lu]PSMA radioligand therapyKerstin Michalski, Juri Ruf, Christian Goetz, et al.
Pageof 32